CHANGES IN MICRORHEOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS DURINGALL-TRANS-RETINOIC ACID (ATRA) DIFFERENTIATION THERAPY - A MECHANISM FOR ATRA-INDUCED HYPERLEUKOCYTOSIS
H. Dombret et al., CHANGES IN MICRORHEOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS DURINGALL-TRANS-RETINOIC ACID (ATRA) DIFFERENTIATION THERAPY - A MECHANISM FOR ATRA-INDUCED HYPERLEUKOCYTOSIS, Leukemia, 9(9), 1995, pp. 1473-1477
According to French and European experience, hyperleukocytosis occurs
during ATRA differentiation therapy in about 70% of de novo and 25% of
relapsed APL cases. The most frequently suggested cause for this side
-effect is an ATRA-induced proliferation of APL cells. However, no def
inite explanation for such a proliferative effect has been clearly est
ablished. Another mechanism directly related to the differentiation of
marrow leukemic cells could be a change in their microrheology, allow
ing their release from the bone marrow and their transfer toward perip
heral blood (PB) and tissues. Using a single cell aspiration assay int
o a glass restrictive channel, we measured APL cell viscosity values i
n five de novo APL patients. A deformability index (DI) was defined as
the ratio of mean normal neutrophil viscosity x 100/mean APL cell vis
cosity. Results were the following: (1) at diagnosis, two patients had
high marrow DI (96 and 250%) and three patients had low marrow DI (16
, 17, and 40%); (2) when PB and marrow APL cells were simultaneously t
ested, PB APL cells display higher DI than marrow APL-cells; (3) the t
wo patients with high initial marrow DI experienced an ATRA-induced hy
perleukocytosis after only 1 day of treatment; (4) in the three patien
ts with low initial marrow DI, the DI was increasing during ATRA thera
py and hyperleukocytosis seemed to occur when a large amount of maturi
ng APL cells reached a viscosity value similar to that of mature neutr
ophils. These results suggest that an asynchronism between theological
and morphological maturation in each APL cell might explain the occur
rence of hyperleukocytosis in some patients during ATRA differentiatio
n therapy.